Considering selenium’s potential in preventing and treating AD, along with the upregulation of SELENOW by selenium levels, our findings suggest that SELENOW could be considered as a potential target of selenium for modulating tau homeostasis in AD. This evidence concerns the gene SELENOW and Alzheimer disease.